Photo by nci from unsplash
Optimal salvage therapy for refractory HLH is unknown.In our patient, ruxolitinib treatment led to clinical remission of refractory HLH. Click to show full abstract
Optimal salvage therapy for refractory HLH is unknown.In our patient, ruxolitinib treatment led to clinical remission of refractory HLH.
Keywords:
refractory hemophagocytic;
ruxolitinib treatment;
treatment refractory;
hemophagocytic lymphohistiocytosis;
refractory
Journal Title: Blood advances
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Blood advances
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!